Medical/Pharmaceuticals

Within weeks of first COVID-19 outbreak, China's Qingdao Weida Biotechnology had switched all production capability over to PPE

QINGDAO, China, July 19, 2021 /PRNewswire/ -- On July 16, 2021, organized by the Information Office of the People's Government of Shandong Province, a delegation of journalists from foreign media organizations who were participating in the 2021 Qingdao Multinationals Summit (QMS) paid a visit to ...

2021-07-20 07:15 1739

ImmVira Launches Pilot-scale Production Line to Expedite the Advancement of Next-generation OV Clinical Trials

SHENZHEN, China, July 18, 2021 /PRNewswire/ -- On July 18, 2021, ImmVira inaugurated a pilot-scale production line inShenzhen and officially initiated its in-house production of our next-generation oncolytic viruses (OV) used for IND applications and Phase I/II clinical trials. Leveraging a strat...

2021-07-19 08:30 2165

Kintor Pharmaceutical Receives Emergency Use Authorization for Proxalutamide for the Treatment of COVID-19 in Paraguay

SUZHOU, China, July 16, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced thatParaguay's Ministry of Public Health and Social Welfare (MSPBS) has granted an emerg...

2021-07-16 14:41 37151

Alterity Therapeutics Announces Publication of Data Demonstrating ATH434 is Neuroprotective and Improves Motor Function

MELBOURNE, Australia, July 15, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today announced thatMovement Disorders, the official jou...

2021-07-15 21:52 37491

GlobalMed Technologies Launches Home-Use Omnilux Contour™ Light Therapy Products in Australia & New Zealand

FDA-Cleared LED Devices are Based on the Gold Standard Omnilux Medical™ System NAPA, Calif., July 16, 2021 /PRNewswire/ -- GlobalMed Technologies (GMT) announced today that it has launched theOmnilux Contour™ line of home-use LED light therapy products in Australia and New Zealand. Contour produ...

2021-07-15 20:00 2174

iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients

WAVRE, Belgium, July 15, 2021 /PRNewswire/ -- iSTAR Medical , a med-tech company developing minimally-invasive implants for glaucoma surgery (MIGS), announced today that the U.S. Food and Drug Administration (FDA) granted it Investigational Device Exemption (IDE) to sta...

2021-07-15 14:00 2485

Kintor Pharmaceutical Collaborates with Fosun Pharma Development to Commercialise Proxalutamide for Treatment of COVID-19 in India and Africa

SUZHOU, China, July 14, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939) today announced that it has entered into a licensing agreement with Shanghai Fosun Pharmaceutical Development Ltd. ("Fosun Pharma Development"), on the commercialisation of proxalutamide for the treatment of CO...

2021-07-15 10:00 34665

Johnson & Johnson Innovation announces extension of innovation partnering office at Monash University in collaboration with Victorian State Government to accelerate the life-sciences hub

- Victorian State Government extends financing of JJIPO@Monash for an additional two years - Extension will further boost Victorian hub for researchers and early-stage companies to connect with industry experts and deliver novel healthcare solutions MELBOURNE, Australia, July 15, 2021 /PRNewswi...

2021-07-15 10:00 2086

Terumo Introduces New AZUR™ Vascular Plug and PG Pro™ Peripheral Microcatheter Embolization System

SOMERSET, N.J., July 14, 2021 /PRNewswire/ -- Terumo Medical Corporation (TMC) has announced today the introduction of its AZUR™ Vascular Plug, the first and only plug compatible with a microcatheter to occlude arteries up to 8mm in diameter. The newest addition to Terumo's robust embolization po...

2021-07-14 20:00 31329

Nippon Express Italia Acquires GDP Certification for Company-owned Warehouse near Milan Malpensa Airport

TOKYO, July 14, 2021 /PRNewswire/ -- Nippon Express Italia S.P.A. (hereinafter " NE Italy"), a local subsidiary of Nippon Express Co., Ltd., obtained Good Distribution Practice (GDP) certification from the certification body CERTIQUALITY S.r.l., effectiveMay 25, for its company-owned warehouse nea...

2021-07-14 15:00 1902

Kintor Pharmaceutical Receives IND Clearance by the U.S. FDA for GT20029 to Treat Androgenetic Alopecia and Acne

SUZHOU, China, July 13, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939), a clinical-stage biotechnology company developing innovative small-molecule and biological therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug...

2021-07-14 07:05 18569

Listen to Your Body with the Newly-launched Amazfit PowerBuds Pro; TWS Earbuds with Advanced Health Monitoring Features

CUPERTINO, Calif., July 13, 2021 /PRNewswire/ -- Today, Amazfit , a brand of Zepp Health (NYSE: ZEPP), launched the Amazfit PowerBuds Pro - their new true wireless stereo (TWS) earbuds with advanced health monitoring features and powerful multi-scenario active noise ...

2021-07-13 21:00 19077

Zepp Health Introduces Next Gen Smart Wearable Chip, Smartwatch OS and Blood Pressure Measurement at Annual Developers Conference

HEFEI, China, July 13, 2021 /PRNewswire/ -- Zepp Health Corp. (NYSE: ZEPP) today  hostedNext Beat 2021 – The Future of Heath, the company's annual developers conference, which included the announcement of several key company developments. Huangsha...

2021-07-13 19:41 17824

GenScript to Host Gene & Cell Engineering Virtual Summit

PISCATAWAY, N.J. , July 13, 2021 /PRNewswire/ -- GenScript® , the world's leading life science service provider, announced today the firstGenScript Gene & Cell Engineering Virtual Summit,

2021-07-13 19:30 49133

Nuctech™ Kylin Care Wins the German Red Dot Award, the "Oscar of the Design World"

BEIJING, July 12, 2021 /PRNewswire/ -- Recently, the German Red Dot Design Award, also known as the "Oscar of the design world", has been officially announced, and Nuctech has won the Red Dot: Best of the Best award, the top prize of Red Dot Award: Design Concept.

2021-07-13 11:30 2419

CD47 Monoclonal Antibody (AK117) Completed Phase I Dose Escalation Trial and Obtained Approval to Initiate Clinical Trial in Combination with Azacitidine for Treatment of Acute Myeloid Leukemia

HONG KONG, July 12, 2021 /PRNewswire/ -- Akeso, Inc. is pleased to announce that, CD47 monoclonal antibody (AK117), a second-generation novel drug for immuno-oncology therapy independently developed by the Company, has completed phase I dose escalation trial inAustralia. AK117 resulted in no dose...

2021-07-13 09:06 2575

Hochuen Medical Raises Tens of Millions RMB in Series A Financing

SHENZHEN, July 12, 2021 /PRNewswire/ -- Hochuen Medical Technology Co., Ltd. (hereinafter referred to as "Hochuen Medical") has raised a40 million Yuan (RMB) Series A round of financing led by Qiming Venture Partners as the sole investor. The new proceeds will be used to (1) accelerate the com...

2021-07-13 01:05 2346

Kintor Pharmaceutical Announced FDA Has Greenlighted Pyrilutamide's Phase II Clinical Trial for Androgenetic Alopecia in the US

SUZHOU, China, July 11, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has greenlighted pyrilutamide's phase...

2021-07-11 21:03 20490

HICOOL 2021 Global Entrepreneurship Competition (Preliminary Round) is Launched in Full Swing on July 10th

BEIJING, July 11, 2021 /PRNewswire/ -- On July 10th, HICOOL 2021 Global Entrepreneurship Competition (Qualifying Round) is launched in full swing. A total of 1,237 startups shortlisted for the preliminary round compete off-line inBeijing and online in a global context in six major industries: New...

2021-07-11 21:00 2422

ABL Bio Announces Publication of Preclinical Data Demonstrating Safety and Efficacy of ABL503/TJ-L14B, a Novel Anti-PD-L1 X 4-1BB Bispecific Antibody

* ABL503/TJ-L14B demonstrates stronger anti-tumor efficacy than anti-PD-L1 or anti-4-1BB monotherapy as well as a good safety profile * ABL503 currently in Phase 1 trial to evaluate the safety, tolerability, MTD PK and PD in patients with advanced or metastatic solid tumors SEONGNAM, South Ko...

2021-07-09 21:00 3871